MetaCap

Who Owns Akebia Therapeutics Stock?

NASDAQ: AKBAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.3855-0.0368 (-8.71%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
41.38%
Institutional holders
210
  • Institutions 41.4%
  • Insiders 2.5%
  • Public and other 56.1%

Who owns Akebia Therapeutics stock?

Institutional investors own about 41.4% of Akebia Therapeutics's shares, spread across 210 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 2.50% of AKBA.

The largest institutional holders are Blackrock Inc. (7.20%), Vanguard Capital Management LLC (4.08%) and AQR Capital Management, LLC (3.30%). Together, the top 10 institutions control 26.9% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their AKBA positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of AKBA

Akebia Therapeutics top institutional holders
InstitutionShares% HeldChange
Blackrock Inc.19.99M7.20%+6.9%
Vanguard Capital Management LLC11.32M4.08%+1.4%
AQR Capital Management, LLC9.15M3.30%+410.5%
Acadian Asset Management. LLC8.97M3.23%+124.0%
Geode Capital Management, LLC6.35M2.29%-5.7%
State Street Corporation5.30M1.91%-1.8%
Jacobs Levy Equity Management, Inc.4.27M1.54%+894.5%
Goldman Sachs Group Inc3.69M1.33%+2.4%
Millennium Management Llc3.20M1.15%+34.0%
Vanguard Portfolio Management LLC2.53M0.91%+14.4%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of AKBA

Akebia Therapeutics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund7.91M2.85%
iShares Trust-iShares Russell 2000 ETF6.83M2.46%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund3.16M1.14%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund2.84M1.02%
iShares Trust-iShares Russell 2000 Growth ETF2.03M0.73%
Fidelity Commonwealth Trust II-Fidelity Enhanced Small Cap Core ETF1.95M0.70%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund1.48M0.53%
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund1.31M0.47%
SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF1.25M0.45%
iShares Trust-iShares Micro-Cap ETF816.91K0.29%

Frequently asked questions

Who is the largest shareholder of Akebia Therapeutics?

Blackrock Inc. is the largest institutional shareholder of AKBA, owning 7.20% of shares outstanding (19.99M shares) as of its latest 13F filing.

What percentage of Akebia Therapeutics is owned by institutions?

Institutions own about 41.4% of AKBA shares and 42.4% of the public float.

How much of Akebia Therapeutics do insiders own?

Insiders, such as officers and directors, own about 2.50% of AKBA shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related